BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19376801)

  • 1. Cellular reprogramming and pluripotency induction.
    Lensch MW
    Br Med Bull; 2009; 90():19-35. PubMed ID: 19376801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and artificial routes to pluripotency.
    Krueger WH; Swanson LC; Tanasijevic B; Rasmussen TP
    Int J Dev Biol; 2010; 54(11-12):1545-64. PubMed ID: 21404178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct reprogramming 101.
    Takahashi K
    Dev Growth Differ; 2010 Apr; 52(3):319-33. PubMed ID: 20298260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic analysis of induced pluripotent stem (iPS) cells: routes to reprogramming.
    Kanawaty A; Henderson J
    Bioessays; 2009 Feb; 31(2):134-8. PubMed ID: 19204985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of isogenic pluripotent stem cells.
    Byrne JA
    Hum Mol Genet; 2008 Apr; 17(R1):R37-41. PubMed ID: 18632695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lazarus's gate: challenges and potential of epigenetic reprogramming of somatic cells.
    Henderson JT
    Clin Pharmacol Ther; 2008 Jun; 83(6):889-93. PubMed ID: 18388874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide reprogramming in hybrids of somatic cells and embryonic stem cells.
    Ambrosi DJ; Tanasijevic B; Kaur A; Obergfell C; O'Neill RJ; Krueger W; Rasmussen TP
    Stem Cells; 2007 May; 25(5):1104-13. PubMed ID: 17272499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear transfer to study the nuclear reprogramming of human stem cells.
    Saito S; Sawai K; Murayama Y; Fukuda K; Yokoyama K
    Methods Mol Biol; 2008; 438():151-69. PubMed ID: 18369756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming.
    Gabut M; Samavarchi-Tehrani P; Wang X; Slobodeniuc V; O'Hanlon D; Sung HK; Alvarez M; Talukder S; Pan Q; Mazzoni EO; Nedelec S; Wichterle H; Woltjen K; Hughes TR; Zandstra PW; Nagy A; Wrana JL; Blencowe BJ
    Cell; 2011 Sep; 147(1):132-46. PubMed ID: 21924763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of novel embryonic stem (ES) cell lines from OG2/rtTA blastocysts.
    Yao H; Jiang Y; Zhang Y; Liu W; Huang B; Wang X; Gao S
    J Genet Genomics; 2011 Jul; 38(7):289-95. PubMed ID: 21777853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear reprogramming and pluripotency of embryonic cells: Application to the isolation of embryonic stem cells in farm animals.
    Renard JP; Maruotti J; Jouneau A; Vignon X
    Theriogenology; 2007 Sep; 68 Suppl 1():S196-205. PubMed ID: 17610945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotency: toward a gold standard for human ES and iPS cells.
    Smith KP; Luong MX; Stein GS
    J Cell Physiol; 2009 Jul; 220(1):21-9. PubMed ID: 19326392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different developmental potential of pluripotent stem cells generated by different reprogramming strategies.
    Jiang J; Ding G; Lin J; Zhang M; Shi L; Lv W; Yang H; Xiao H; Pei G; Li Y; Wu J; Li J
    J Mol Cell Biol; 2011 Jun; 3(3):197-9. PubMed ID: 21624975
    [No Abstract]   [Full Text] [Related]  

  • 16. Nuclear reprogramming in cells.
    Gurdon JB; Melton DA
    Science; 2008 Dec; 322(5909):1811-5. PubMed ID: 19095934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic control of early mouse development.
    Albert M; Peters AH
    Curr Opin Genet Dev; 2009 Apr; 19(2):113-21. PubMed ID: 19359161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factors for the modulation of pluripotency and reprogramming.
    Heng JC; Orlov YL; Ng HH
    Cold Spring Harb Symp Quant Biol; 2010; 75():237-44. PubMed ID: 21047904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pluripotent reprogramming of fibroblasts by lentiviral mediated insertion of SOX2, C-MYC, and TCL-1A.
    Picanço-Castro V; Russo-Carbolante E; Reis LC; Fraga AM; de Magalhães DA; Orellana MD; Panepucci RA; Pereira LV; Covas DT
    Stem Cells Dev; 2011 Jan; 20(1):169-80. PubMed ID: 20504151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics in embryonic stem cells: regulation of pluripotency and differentiation.
    Atkinson S; Armstrong L
    Cell Tissue Res; 2008 Jan; 331(1):23-9. PubMed ID: 18004593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.